Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00378105 · MORE INFO

Limitations, agreements, and source contact

Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma · Source last updated 2026-02-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
GT60
restrictive Agreement
true
point Of Contact
email
Paul_Richardson@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-2104
title
Dr. Richardson
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
GT60
restrictive Agreement
true
point Of Contact
email
Paul_Richardson@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-2104
title
Dr. Richardson

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice